Quintex Pharma and GL Rapha Announce Formation of Quinn Biopharma Ltd to Advance Pharmaceutical Manufacturing in Sub-Saharan Africa


Quintex Pharma and GL Rapha Announce Formation of Quinn Biopharma Ltd to Advance Pharmaceutical Manufacturing in Sub-Saharan Africa

Seoul, South Korea — April 29, 2025 — Quintex Pharma Ltd of Ghana and GL Rapha Co., Ltd of Korea have officially announced the formation of Quinn Biopharma Ltd, a groundbreaking joint venture that aims to transform pharmaceutical manufacturing in Sub-Saharan Africa.

Ghana’s pharmaceutical sector currently meets approximately 30% of domestic pharmaceutical demand through local production, with the remaining 70% fulfilled by imports.

The new company, Quinn Biopharma Ltd, will focus on developing a state-of-the-art sterile injectable pharmaceutical manufacturing facility in Ghana. Leveraging GL Rapha’s world-class biotechnology and Quintex Pharma’s local expertise, the venture aims to raise the standard of pharmaceutical manufacturing and improve access to high-quality medicines across the region.

A feasibility study for the project was conducted by a consortium comprising IQVIA, AMPC International, and PwC, with strategic financial and technical support from the Ghana Jobs and Economic Transformation (JET) Programme, an initiative of the UK Government supporting Ghana’s industrialisation.

The official signing ceremony took place in Seoul, Korea, on April 29, 2025.

Attendees at the Signing Ceremony:

  • GL Rapha: Mr. Whang Jae Gan, Chairman
  • Quintex Pharma: Dr. Kwesi Nyan Amissah-Arthur, CEO; Ms. Emefa Mensah-Tandoh, Head of Legal
  • Ghana JET: Mr. Eugene Sangmortey, Team Leader; Mr. Louis Nortey, Pharmaceutical Sector Lead
  • Ghana Ministry of Trade, Agribusiness and Industry: Mr. Kwasi Ofori-Antwi, Head of Strategic Sectors

Statements from Leaders:

“Quinn Biopharma represents a bold step toward pharmaceutical self-sufficiency for Sub-Saharan Africa, delivering world-class medicines manufactured in Africa by Africans, for the World.”

— Dr. Kwesi Nyan Amissah-Arthur, CEO, Quintex Pharma

“GL Rapha is proud to bring our advanced biotechnology to Ghana, fostering a partnership that will not only create high-quality products but also build local capacity and expertise for the future.”

— Mr. Whang Jae Gan, Chairman, GL Rapha

The formation of Quinn Biopharma Ltd underscores a shared vision to foster industrial innovation, build resilient health systems, and strengthen Africa’s pharmaceutical supply chain in line with regional public health goals.

About Quintex Pharma

Quintex Pharma is a Delaware-based holding company with pharmaceutical manufacturing operations in Akuse, Ghana. The company is dedicated to providing high-quality generic medications and contract manufacturing services to improve healthcare access and quality in Africa.

About GL Rapha

GL Rapha Co., Ltd is a leading Korean biotechnology and pharmaceutical company specialising in the development and manufacture of advanced biologics, vaccines, and sterile injectables for global markets.

About Ghana JET

Implemented by the Palladium Group, the UK Government-funded Ghana Jobs and Economic Transformation (JET) Programme helps drive economic transformation in Ghana by facilitating private investment in strategic manufacturing sectors—such as pharmaceuticals—to create high-quality jobs.

Media Contact Information

Quintex Pharma Ltd

Email: [email protected]

Phone: +233 (0)30 2789987

GL Rapha

Email: [email protected]

Phone: +82 10 2261 0158

Ghana JET

Email: [email protected]

Phone: +233 (0)24 414 1515



Which comes first in West Africa? Pharmaceutical regulatory convergence or regional market access.

FOR IMMEDIATE RELEASE Quintex Pharma Signs Technical Transfer Agreement with Fabtech Technologies Ltd for Pharmaceutical Manufacturing Intellectual Property Delaware 27th November 2023 — Quintex Pharma, a Delaware based start-up pharmaceutical manufacturing company with its planned production base to be situated in Ghana, is thrilled to announce the signing of a ground breaking Technical Transfer Agreement with Fabtech Technologies Ltd, a renowned global innovator in pharmaceutical manufacturing solutions. This strategic collaboration marks a significant milestone in Quintex Pharma's mission to enhance healthcare access and quality across West Africa. The Technical Transfer Agreement encompasses the transfer of valuable pharmaceutical manufacturing intellectual property from Fabtech Technologies Ltd to Quintex Pharma, facilitating the expansion of Quintex Pharma's product portfolio and manufacturing capabilities. Fabtech Technologies Ltd, with its extensive experience and expertise in pharmaceutical manufacturing processes and technologies, will be instrumental in aiding Quintex Pharma's efforts to bolster its production capacities and optimize its manufacturing processes. This transfer of knowledge and technology is expected to strengthen Quintex Pharma's position as a leading provider of high-quality generic medications and contract manufacturing services in the region. Quintex Pharma is excited about the partnership: "This collaboration with Fabtech Technologies Ltd represents a significant step forward in our journey to provide affordable and effective pharmaceutical products in West Africa. We are confident that the transfer of intellectual property and technical expertise will enable us to develop and manufacture high-quality pharmaceuticals that meet the evolving healthcare needs of our region." Fozi Al Kailani, the representative of Fabtech Technologies Ltd, shared his enthusiasm for the collaboration: "We are pleased to partner with Quintex Pharma, a company that shares our commitment to innovation, quality, and improving healthcare access. This Technical Transfer Agreement aligns with Fabtech's mission to empower pharmaceutical manufacturers worldwide with cutting-edge technology and know-how." As Quintex Pharma and Fabtech Technologies Ltd embark on this mutually beneficial partnership, they anticipate that it will lead to innovations in pharmaceutical manufacturing, higher product quality, and increased availability of essential medications in West Africa. Both companies are committed to upholding the highest standards of quality and regulatory compliance throughout this collaboration. For media inquiries or more information about Quintex Pharma's Technical Transfer Agreement with Fabtech Technologies Ltd, please contact: Quintex Pharma corporate affairs team: [email protected] About Quintex Pharma: Quintex Pharma is a Delaware holdCo with pharmaceutical manufacturing based in Akuse, Ghana. Quintex Pharma is dedicated to providing high-quality generic medications and contract manufacturing services to improve healthcare access and quality in West Africa. About Fabtech Technologies Ltd: Fabtech Technologies Ltd is a global leader in pharmaceutical manufacturing solutions, specializing in cutting-edge technology and expertise for pharmaceutical manufacturers worldwide.